● Recruiting

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Condition: Chronic Coronary Syndrome · Stable Coronary Artery Disease CAD · Sponsor: Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.

PhasePhase 3

Planned participants1703

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to compare the effect of prasugrel plus low-dose aspirin versus high dose aspirin alone (300mg) and versus low dose aspirin alone (75 mg) in patients with chronic coronary disease undergoing coronary artery bypass grafting.

This description comes directly from the study's public registry record.

Talk to the study team

Aleksandra Pawlik · +48 71 320 94 50 · badaniakliniczne@medinet.pl

Always discuss trial participation with your own doctor first.

Locations (18)

University Clinical Hospital in Bialystok	Bialystok, Poland	Not Yet Recruiting
Nicolaus Copernicus University Ludwik Rydygier Collegium Medicum in Bydgoszcz	Bydgoszcz, Poland	Not Yet Recruiting
Medical University of Gdansk	Gdansk, Poland	Not Yet Recruiting
Regional Specialist Hospital in Grudziadz	Grudziądz, Poland	Not Yet Recruiting
Upper-Silesian Heart Center	Katowice, Poland	Active Not Recruiting
John Paul II Hospital	Krakow, Poland	Not Yet Recruiting
Medical University of Lodz	Lodz, Poland	Not Yet Recruiting
Zbigniew Religa Heart Center "Medinet"	Nowa Sól, Poland	Recruiting
Provincial Specialist Hospital in Olsztyn	Olsztyn, Poland	Not Yet Recruiting
Institute of Medical Sciences in Opole	Opole, Poland	Not Yet Recruiting
J. Struś Hospital	Poznan, Poland	Not Yet Recruiting
Poznan University of Medical Sciences	Poznan, Poland	Active Not Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07195149